Loading...
•
Mar 31, 2021
DexCom Q1 2021 Earnings Report
Dexcom's first quarter results for 2021 showed revenue growth and strategic advancements.
Key Takeaways
Dexcom reported a strong start to 2021 with a 25% increase in revenue compared to the same quarter last year, reaching $505.0 million. The company saw growth in both U.S. and international markets and raised its full-year revenue guidance based on these results.
Revenue grew 25% year-over-year to $505.0 million.
U.S. revenue increased by 30%, while international revenue grew by 10%.
GAAP operating income was $45.9 million, representing 9.1% of revenue.
The company raised its 2021 revenue guidance based on the strength of the first quarter results.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Dexcom is increasing its guidance for fiscal year 2021 revenue, and reiterating prior guidance for gross margin, Non-GAAP operating margin, and Adjusted EBITDA margin.
Positive Outlook
- Revenue of approximately $2.26 - 2.36 billion (17-22% growth)
- Non-GAAP Gross Profit Margin of approximately 65%
- Non-GAAP Operating Margin of approximately 13%
- Adjusted EBITDA Margin of approximately 23%
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...